Corporate insider profile

Roger Jeffs Filing Activity

Latest reported as Director of Axsome Therapeutics, Inc. (AXSM).

Purchase filings: 0
Reported companies: 2
Net open-market value: -$25,374,621.73
Latest transaction: Jun 11, 2026

Affiliated corporations

Reported company relationships

AXSMLatest reported

Axsome Therapeutics, Inc.

Director

LQDAPrior filing

Liquidia Corp

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
Date	Company	Role	Type	Shares	Price	Total value
Jun 11, 2026	Axsome Therapeutics, Inc. (AXSM)	Director	Sale	572	$247.65	$141,656
May 27, 2026	Liquidia Corp (LQDA)	Chief Executive Officer	Sale	6,428	$62.18	$399,712
May 26, 2026	Liquidia Corp (LQDA)	Chief Executive Officer	Sale	75,000	$61.01	$4,575,675
Jun 18, 2026	Executive Name	Chief Financial Officer	Sale	00,000	$00.00	$0,000,000
May 29, 2026	Executive Name	Director	Sale	0,000	$00.00	$000,000

Subscribe to see more data